Dispersyn Gerrit 4
4 · Phio Pharmaceuticals Corp. · Filed Mar 5, 2021
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Purchase
Common stock, $0.0001 par value
2021-03-04$2.56/sh+1,953$5,000→ 89,281 total
Footnotes (1)
- [F1]Includes shares of common stock underlying unvested restricted stock units.